Simmonds H A, Panayi G S, Corrigall V
Lancet. 1978 Jan 14;1(8055):60-3. doi: 10.1016/s0140-6736(78)90002-8.
We have investigated a new hypothesis for the association between adenosine deaminase (A.D.A.) deficiency and immunodeficiency--namely, that deoxyadenosine rather than adenosine (an equally effective A.D.A. substrate) is toxic to proliferating cells of lymphoid origin. This possibility was explored in mitogen-stimulated lymphocytes cultured with a potent A.D.A. inhibitor, E.H.N.A. (erythro-9[2-hydroxy-3-nonyl] adenine) to simulate A.D.A. deficiency. In this in-vitro system deoxyadenosine was inhibitory at much lower and more physiological concentrations (1 mumol/1), compared with adenosine (100 mumol/1).
我们研究了腺苷脱氨酶(A.D.A.)缺乏与免疫缺陷之间关联的一种新假说,即脱氧腺苷而非腺苷(一种同样有效的A.D.A.底物)对淋巴源性增殖细胞具有毒性。在用强效A.D.A.抑制剂E.H.N.A.(erythro-9[2-hydroxy-3-nonyl] adenine,赤藓红-9[2-羟基-3-壬基]腺嘌呤)培养的丝裂原刺激淋巴细胞中探索了这种可能性,以模拟A.D.A.缺乏。在这个体外系统中,与腺苷(100 μmol/L)相比,脱氧腺苷在低得多且更接近生理浓度(1 μmol/L)时就具有抑制作用。